[1] |
HUANG Haozhe, CHEN Hong, ZHENG Dezhong, CHEN Chao, WANG Ying, XU Lichao, WANG Yaohui, HE Xinhong, YANG Yuanyuan, LI Wentao.
A CT-based radiomics nomogram for predicting local tumor progression of colorectal cancer lung metastases treated with radiofrequency ablation
[J]. China Oncology, 2024, 34(9): 857-872.
|
[2] |
PAN Jian, YE Dingwei, ZHU Yao, WANG Beihe.
Correlation analysis of PSMA PET/CT-derived parameters and circulating tumor DNA features in patients with hormone-sensitive prostate cancer
[J]. China Oncology, 2024, 34(7): 680-685.
|
[3] |
JIANG Tiaoyan, JIA Tianying, ZHANG Qin.
Contrast-enhanced computed tomography-based radiomics models for the risk categorization of thymoma
[J]. China Oncology, 2024, 34(6): 581-589.
|
[4] |
LIN Jiaxin, WEI Ran, SHUI Ruohong, LU Hongfen, LI Xiaoqiu, YU Baohua.
Clinicopathological analysis of adrenal intravascular large B-cell lymphoma
[J]. China Oncology, 2024, 34(11): 1020-1027.
|
[5] |
LIU Wei, XIE Tiansong, CHEN Lei, ZHANG Zehua, ZHOU Zhengrong.
Investigating the value of dual-layer spectral detector CT in distinguishing resectable pancreatic ductal adenocarcinoma from mass-forming chronic pancreatitis
[J]. China Oncology, 2024, 34(1): 67-73.
|
[6] |
YANG Ziyi, GU Bingxin, XU Xiaoping, SONG Shaoli.
Comparison of 18F-FDG and 68Ga-FAPI PET/CT in the diagnosis of lung metastasis in different malignant tumors
[J]. China Oncology, 2023, 33(9): 829-833.
|
[7] |
TIAN Xi, XU Wenhao, ZHU Shuxuan, AIHETAIMUJIANG•Anwaier, SU Jiaqi, YE Shiqi, QU Yuanyuan, SHI Guohai, ZHANG Hailiang, YE Dingwei.
Advances in the research, diagnosis and treatment of renal cell carcinoma in 2022
[J]. China Oncology, 2023, 33(3): 191-200.
|
[8] |
SU Jiaqi, XU Wenhao, TIAN Xi, ANWAIE Aihetaimujiang, QU Yuanyuan, SHI Guohai, ZHANG Hailiang, YE Dingwei.
New strategies for combined with immunotherapy of clear cell renal cell carcinoma: advances in aerobic glycolysis
[J]. China Oncology, 2022, 32(4): 287-297.
|
[9] |
ZHOU Bingni, LIU Xiaohang, GU Bingxin, ZHOU Liangping, GU Yajia.
The value of mpMRI combined with 99mTc-PSMA SPECT/CT in the detection of significant residual prostate cancer after neoadjuvant androgen deprivation therapy
[J]. China Oncology, 2022, 32(2): 134-141.
|
[10] |
CAO Dalong, YE Dingwei.
New trends and future prospects of regulatory cell death in renal carcinoma
[J]. China Oncology, 2022, 32(10): 1000-1006.
|
[11] |
LEI Kunyang, XIE Wenjie, SUN Ting, LIU Yifu, WANG Xu.
Expression and effect of long non-coding RNA ARAP1-AS1 in clear cell renal cell carcinoma
[J]. China Oncology, 2022, 32(1): 34-40.
|
[12] |
XU Wenhao, TIAN Xi, Aihetaimujiang·Anwaier , QU Yuanyuan, SHI Guohai, ZHANG Hailiang, YE Dingwei.
A systematic review of current advancements of artificial intelligence in genitourinary cancers
[J]. China Oncology, 2022, 32(1): 68-74.
|
[13] |
YANG Yanju, ZHONG Yang, HU Weigang, GAO Dadi, ZHAO Jun.
Effects of CT-RED calibration curves of different simulators on dose distribution of tumor target and organs at risk
[J]. China Oncology, 2021, 31(9): 828-837.
|
[14] |
LUO Rong , HU Peian , XIE Tiansong , ZHANG Zehua , ZHOU Liangping , ZHOU Zhengrong , CHEN Lei .
The correlation of imaging, clinical features and pathology of myxoid fibrosarcoma
[J]. China Oncology, 2021, 31(8): 734-739.
|
[15] |
HU Guannan , CHEN Lei , ZHOU Liangping , ZHOU Zhengrong .
A case report of pulmonary malignant melanoma complicated with lung adenocarcinoma and literature review
[J]. China Oncology, 2021, 31(7): 647-650.
|